EXACTUS, INC. (OTCMKTS:EXDI) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
Item 5.02
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
Resignation of James R. Erickson
On February 21, 2019, we executed a Termination Agreement and Mutual Release with James R. Erickson (the “Agreement”). Under the Agreement, Mr. Erickson terminated his service as our Chief Business Officer. The Agreement contains mutual releases between the parties.
Section 9 – FINANCIAL STATEMENTS AND EXHIBITS
Item 9.01
Financial Statements and Exhibits
|
Exhibit No. |
Description |
|
Termination Agreement and Mutual Release with James R. Erickson |
|
Exactus, Inc. Exhibit
EX-10.1 2 ex10-1.htm TERMINATION AGREEMENT AND MUTUAL RELEASE WITH JAMES R. ERICKSON Blueprint Exhibit 10.1 TERMINATION AGREEMENT AND MUTUAL RELEASE This Termination Agreement and Mutual Release (“Agreement”) is made this 21st day of February,…
To view the full exhibit click here
About EXACTUS, INC. (OTCMKTS:EXDI)
Exactus, Inc. (Exactus), formerly Spiral Energy Tech, Inc., is a life science company. The Company will develop and commercialize Point-of-Care (POC) diagnostics for measuring proteolytic enzymes in the blood based on a detection platform. The Company’s primary business focus will be the development and commercialization of the FibriLyzer and related technology licensed by Exactus. The Company’s products will employ a disposable test biosensor strip combined with a portable hand held detection unit that provides a result in approximately 30 seconds. The Company intends to file to gain regulatory approval and launch its products in the United States and Europe.